Delayed Presentations and Worse Outcomes After Aneurysmal Subarachnoid Hemorrhage in the Early COVID-19 Era
BACKGROUND:
The early phase of the COVID-19 pandemic led to significant healthcare avoidance, perhaps explaining some of the excess reported deaths that exceeded known infections. The impact of the early COVID-19 era on aneurysmal subarachnoid hemorrhage (aSAH) care remains unclear.
OBJECTIVE:
To determine the impact of the early phase of the COVID-19 pandemic on latency to presentation, neurological complications, and clinical outcomes after aSAH.
METHODS:
We performed a retrospective cohort study from March 2, 2012, to June 30, 2021, of all patients with aSAH admitted to our center. The early COVID-19 era was defined as March 2, 2020, through June 30, 2020. The pre–COVID-19 era was defined as the same interval in 2012 to 2019.
RESULTS:
Among 499 patients with aSAH, 37 presented in the early COVID-19 era. Compared with the pre–COVID-19 era patients, patients presenting during this early phase of the pandemic were more likely to delay presentation after ictus (median, interquartile range; 1 [0-4] vs 0 [0-1] days, respectively, P
Source: Neurosurgery - Category: Neurosurgery Tags: Research—Human—Clinical Studies: Cerebrovascular Source Type: research
More News: Brain | COVID-19 | Neurology | Neurosurgery | Pandemics | Study | Subarachnoid Hemorrhage